NovaBridge Biosciences
NBP
$2.06
-$0.04-1.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.86M | -6.83M | -- | -- | -10.84M |
| Total Depreciation and Amortization | 216.00K | 216.00K | -- | -- | 213.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.77M | 1.46M | -- | -- | 812.00K |
| Change in Net Operating Assets | 10.28M | 6.99M | -- | -- | -1.13M |
| Cash from Operations | -14.60M | 1.84M | -- | -- | -10.95M |
| Capital Expenditure | 0.00 | 0.00 | -- | -- | -38.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -- | -- | -71.00K |
| Cash from Investing | 0.00 | 0.00 | -- | -- | -109.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 200.00K | 61.71M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.22M | -966.00K | -- | -- | -- |
| Cash from Financing | -3.02M | 60.75M | -- | -- | 0.00 |
| Foreign Exchange rate Adjustments | 187.00K | 73.00K | -- | -- | -6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.43M | 62.66M | -- | -- | -11.06M |